EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,496 | +1.8% | 1,899,151 | -11.0% | 15.28% | +18.3% |
| Q2 2023 | $40,775 | -1.6% | 2,133,703 | -0.1% | 12.92% | +2.6% |
| Q1 2023 | $41,457 | +20.9% | 2,135,868 | -0.1% | 12.59% | +18.8% |
| Q4 2022 | $34,294 | -99.9% | 2,138,039 | +17.4% | 10.60% | +16.5% |
| Q3 2022 | $28,561,000 | -9.0% | 1,821,475 | +20.9% | 9.09% | -12.3% |
| Q2 2022 | $31,373,000 | -9.6% | 1,506,885 | -1.5% | 10.37% | -13.3% |
| Q1 2022 | $34,694,000 | +21.9% | 1,530,406 | -1.7% | 11.96% | +21.1% |
| Q4 2021 | $28,464,000 | +34.6% | 1,557,119 | +55.7% | 9.87% | +48.9% |
| Q3 2021 | $21,140,000 | – | 1,000,000 | – | 6.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |